Advances and challenges in the treatment of lung cancer.
Li Y, Yan B, He S.
Biomed Pharmacother. 2023 Dec 31;169:115891. doi: 10.1016/j.biopha.2023.115891. Epub 2023 Nov 16.
Non-small cell lung cancer (NSCLC): A review of risk factors, diagnosis, and treatment.
Alduais Y, Zhang H, Fan F, Chen J, Chen B.
Medicine (Baltimore). 2023 Feb 22;102(8):e32899. doi: 10.1097/MD.0000000000032899.
New promises and challenges in the treatment of advanced non-small-cell lung cancer.
Meyer ML, Fitzgerald BG, Paz-Ares L, Cappuzzo F, Jänne PA, Peters S, Hirsch FR.
Lancet. 2024 Aug 24;404(10454):803-822. doi: 10.1016/S0140-6736(24)01029-8. Epub 2024 Aug 6.
Update 2020: Management of Non-Small Cell Lung Cancer.
Alexander M, Kim SY, Cheng H.
Lung. 2020 Dec;198(6):897-907. doi: 10.1007/s00408-020-00407-5. Epub 2020 Nov 11.
Toward personalized treatment approaches for non-small-cell lung cancer.
Wang M, Herbst RS, Boshoff C.
Nat Med. 2021 Aug;27(8):1345-1356. doi: 10.1038/s41591-021-01450-2. Epub 2021 Aug 12.
Radiotherapy treatment for lung cancer: Current status and future directions.
Vinod SK, Hau E.
Respirology. 2020 Nov;25 Suppl 2:61-71. doi: 10.1111/resp.13870. Epub 2020 Jun 9.
Stage III Non-Small-Cell Lung Cancer: An Overview of Treatment Options.
Petrella F, Rizzo S, Attili I, Passaro A, Zilli T, Martucci F, Bonomo L, Del Grande F, Casiraghi M, De Marinis F, Spaggiari L.
Curr Oncol. 2023 Mar 7;30(3):3160-3175. doi: 10.3390/curroncol30030239.
Lung cancer: Biology and treatment options.
Lemjabbar-Alaoui H, Hassan OU, Yang YW, Buchanan P.
Biochim Biophys Acta. 2015 Dec;1856(2):189-210. doi: 10.1016/j.bbcan.2015.08.002. Epub 2015 Aug 19.
Extensive-Stage Small-Cell Lung Cancer: First-Line and Second-Line Treatment Options.
Zugazagoitia J, Paz-Ares L.
J Clin Oncol. 2022 Feb 20;40(6):671-680. doi: 10.1200/JCO.21.01881. Epub 2022 Jan 5.
Advancements in small cell lung cancer.
Lee JH, Saxena A, Giaccone G.
Semin Cancer Biol. 2023 Aug;93:123-128. doi: 10.1016/j.semcancer.2023.05.008. Epub 2023 May 24.
